WBA Stock Rises 0.50% on Heavy Volume Trading Apr 24

Walgreens Boots Alliance, Inc. (WBA) gained 0.50% to close at $11.98 USD on NASDAQ during intraday trading on April 24, 2026. The pharmacy-led retailer saw exceptional trading volume of 452 million shares, significantly above its 30-day average of 16.9 million. This surge in activity reflects investor interest despite ongoing profitability challenges. WBA stock has climbed 30.36% year-to-date but remains down 63.06% over three years. The company operates over 13,000 retail locations globally and continues navigating a competitive healthcare landscape.

WBA Stock Performance and Trading Activity

WBA stock opened at $11.98 and maintained that level throughout the session, showing stability in a volatile market. The 0.50% gain represents modest upward momentum as traders actively positioned themselves ahead of upcoming earnings. Volume surged to 452 million shares, indicating strong institutional and retail participation.

The stock trades well below its 52-week high of $13.25 but above its low of $8.08. Year-to-date performance of +30.36% shows recovery from pandemic lows, though the three-year decline of -63.06% reflects structural challenges in brick-and-mortar retail. Track WBA on Meyka for real-time updates on price movements and volume trends.

Financial Metrics and Valuation Concerns

Walgreens Boots Alliance faces significant profitability headwinds reflected in negative earnings metrics. The company reported a negative EPS of -$7.29, resulting in a distorted PE ratio of -1.64. Revenue per share stands at $135.31, but net income per share is deeply negative at -$3.81.

Key valuation metrics reveal stress: the price-to-sales ratio of 0.09 appears attractive, but this masks underlying operational challenges. Free cash flow per share is negative at -$0.59, indicating the company burns cash despite strong revenue generation. Debt-to-equity ratio of 4.04 signals heavy leverage, while the current ratio of 0.60 suggests potential liquidity concerns requiring management attention.

Market Sentiment and Analyst Outlook

Analyst consensus remains cautious on WBA stock. One analyst maintains a Sell rating, reflecting skepticism about near-term recovery prospects. The company’s Meyka AI grade of C+ with a Hold suggestion indicates mixed fundamentals that don’t warrant aggressive positioning.

The rating factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Earnings are scheduled for announcement on June 25, 2025, which could provide clarity on turnaround efforts. These grades are not guaranteed and we are not financial advisors. Trading activity suggests some investors see value at current levels, though institutional support remains limited.

Operational Challenges and Strategic Position

Walgreens operates 8,965 U.S. retail stores under the Walgreens and Duane Reade banners, plus 4,031 international locations. The company employs 1.93 million people globally, making it a major healthcare employer. However, negative operating margins of -1.83% and declining profitability metrics signal operational strain.

Gross profit margin of 17.28% remains respectable, but operating losses erode shareholder value. Return on equity of -38.81% and return on assets of -4.74% demonstrate poor capital efficiency. Management must address cost structure and improve operational efficiency to restore investor confidence and stabilize WBA stock performance.

Final Thoughts

WBA stock’s 0.50% gain and exceptional trading volume reflect cautious investor interest in the pharmacy giant despite significant headwinds. The company’s negative earnings, high leverage, and operational challenges create a complex investment picture. While the year-to-date recovery of 30.36% shows some resilience, the three-year decline of -63.06% underscores structural pressures facing traditional retail pharmacies. Walgreens must demonstrate sustainable profitability improvements before attracting broader institutional support. Investors should monitor June earnings closely for signs of turnaround progress. The current valuation may appeal to value hunters, but execution risk remains elevated.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.